Assay method for Alzheimer's disease
US8444977B2 · kind B2 · utility
0Cited by
18References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 12, 2010 |
| Grant date | May 21, 2013 |
| Priority date | — |
| Expiry date | Jul 12, 2030 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/2821
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A diagnostic test for preclinical and clinical Alzheimer's disease is based on plasma levels of Aβ40, Aβ42, their ratio, or their rate of entry following administration of antibodies that sequester Aβ. Alterations of any of these parameters from control values identifies preclinical or clinical Alzheimer's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.